Bausch & Lomb has bought the commercial assets of Tubilux Pharma, a private ophthalmic pharmaceuticals company based in Italy. The terms of the deal were not released, but B&L has bought Tubilux' ophthalmic pharmaceuticals portfolio in addition to its commercial and sales operations. Tubilux will keep its manufacturing operation, making ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.